| Characteristics of Hypertension in the Chinese Population. | |
| | |
MedLine Citation:
|
PMID: 22843493 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
In China, the prevalence of hypertension is currently 18.8 %, and a major risk factor for hypertension is unbalanced dietary sodium and potassium intakes. High dietary sodium intake may change the circadian rhythm of 24-h blood pressure, which is characterized by a higher nighttime blood pressure. The prevalence of isolated nighttime hypertension, defined as a nighttime blood pressure of at least 120 mm Hg systolic or 70 mm Hg diastolic and a daytime systolic/diastolic blood pressure less than 135/85 mm Hg, is higher in Chinese than in Europeans. The complications of hypertension are also different across ethnicities, being mainly stroke instead of myocardial infarction in Chinese. Lowering of blood pressure provides more protection against stroke than against myocardial infarction, and calcium channel blockers provide more protection against stroke than do other classes of antihypertensive drugs. Current Chinese hypertension guidelines recommend calcium channel blockers as the most suitable class of drugs of the five classes of antihypertensive drugs. |
| | |
Authors:
|
Ji-Guang Wang; Yan Li |
Related Documents
:
|
19666123 - Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 g... 19596363 - Angiotensin-converting enzyme insertion/deletion polymorphism has no effect on the risk... 6701253 - Behavioral response demands, cardiovascular reactivity, and essential hypertension. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-7-29 |
Journal Detail:
|
Title: Current hypertension reports Volume: - ISSN: 1534-3111 ISO Abbreviation: - Publication Date: 2012 Jul |
Date Detail:
|
Created Date: 2012-7-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100888982 Medline TA: Curr Hypertens Rep Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Ruijin 2nd Road 197, Shanghai, 200025, China, jiguangwang@aim.com. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Autologous Regulatory T Cells for the Treatment of Type 1 Diabetes.
Next Document: The Ubiquitous Mineralocorticoid Receptor: Clinical Implications.